Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Innopsys' InnoScan 710-IR Scanner, Kinexus' Kinex Antibody Microarray Kit

Premium

French optics firm Innopsys recently introduced its InnoScan 710-IR microarray scanner.

The company said the confocal scanner is equipped with two excitation lasers capable of reading signals in the near infrared spectrum and is suited for protein and cell microarray applications. Compared to the red and green lasers used in some array scanners, Innopsys claims that the infrared lasers in the InnoScan 710-IR allow reduction in background noise caused by supports used in protein array applications, such as nitrocellulose and polyvinylidene difluoride.


Kinexus this week launched its Kinex Antibody Microarray Kit with its latest generation KAM-850 chip.

The new antibody microarray is capable of tracking the levels and functional states of hundreds of diverse proteins in human and animal cell and tissue specimens and features more than 330 phosphosite- and 540 pan-specific antibody probes.

This provides researchers with a tool to study changes in cell signaling proteins that occur in response to a range of treatments, drugs, toxins, pathological and other experimental conditions, according to the Vancover, Canada-based firm.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.